PMID: 8960119Aug 1, 1996Paper

Involvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switching

Molecular Immunology
A N GoldfarbK Lewandowska

Abstract

The basic helix-loop-helix (bHLH) transcriptional factor E2A has previously been shown to play a critical role in early B cell development, with E2A knockout mice and Id1 transgenic mice showing an arrest at the pro-B cell stage of development. More recent data suggest that E2A, through an interaction with the immunoglobulin heavy chain 3' enhancer, might also regulate later events in B cell development such as heavy chain class switching. The patterns of E2A protein expression in secondary lymphoid tissues support a role in later stages of B cell maturation. In particular, immunostaining reveals upregulation of E2A protein in cells of the dark zone of the germinal center, the site of immunoglobulin heavy chain class switching. To examine the role of E2A in class switching, the inhibitory HLH protein Id1 was expressed in B cell lines which normally undergo spontaneous and inducible switching from IgM to IgA. The forced expression of Id1 in these cell lines effectively blocked class switching. This Id1 blockade of class switching did not occur via downregulation of immunoglobulin heavy chain germline transcription or through inhibition of cell cycling. Furthermore, Id1 inhibited spontaneous and, to a lesser degree, cytokine indu...Continue Reading

References

Apr 1, 1994·The Journal of Experimental Medicine·Y WakatsukiW Strober
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G A Daniels, M R Lieber
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·A F Voronova, F Lee
Jul 1, 1993·The Journal of Experimental Medicine·Y Wakatsuki, W Strober
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·V J RobertsC Murre

❮ Previous
Next ❯

Citations

Dec 31, 2003·Gene·Kikumi Hata, Junichiro Mizuguchi
May 29, 1998·Current Opinion in Immunology·T Reya, R Grosschedl
Oct 22, 2005·Nature Immunology·Cornelis Murre
Nov 7, 2006·Nature Immunology·Michael A CannarileAnanda W Goldrath
Mar 10, 2001·Cold Spring Harbor Symposia on Quantitative Biology·C Murre
Dec 28, 1999·Molecular and Cellular Biology·M E Massari, C Murre
Feb 28, 2002·Annual Review of Immunology·Tasuku HonjoMasamichi Muramatsu
Feb 28, 2002·Annual Review of Immunology·Melanie W QuongCornelis Murre
Jan 19, 2000·Clinical Immunology : the Official Journal of the Clinical Immunology Society·K Zhang, H K Cheah
Feb 13, 2001·Mechanisms of Development·S H HsuH Li
Apr 30, 2003·Nature Immunology·Camil Elie SayeghCornelis Murre
Feb 5, 2003·The Journal of Biological Chemistry·Mathieu TremblayTrang Hoang
Sep 29, 2006·Journal of Medical Microbiology·Hatice OzbilgeSuleyman Yazar
Aug 24, 1999·Molecular and Cellular Biology·L PanY Zhuang
Oct 19, 2001·Oncogene·S E AsplandC Murre
Jul 17, 1998·The American Journal of Pathology·M N Rutherford, D P LeBrun

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.